Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

NCT00003525 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Cervical Cancer Stage IV
Vulvar Cancer, Stage IV

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute